SA joins measles vaccine trial in Covid-19 fight
Health-care workers in SA to be part of MMR vaccine trial as a stopgap pandemic measure
Researchers are preparing to launch the SA leg of an international trial investigating whether the well-established measles, mumps and rubella (MMR) shot used in childhood immunisation programmes can protect front-line health-care workers from Sars-CoV-2, the virus that causes Covid-19.
More than 170 potential Covid-19 vaccines are being developed worldwide, but only nine are in late-stage phase 3 efficacy trials, and none has yet been approved by regulators, says the World Health Organisation. Researchers are thus also investigating whether tried-and-tested vaccines that provide protection from diseases as diverse as polio, tuberculosis and measles might provide a stopgap measure against Covid-19...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.